Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Shulman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of the American Dental Association (1939)|January 2, 2007
Occlusal discrepanciesJeremy Shulman
Journal of the California Dental Association|January 29, 2016
TMD Controversy ContinuesJeremy Shulman
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2021
Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-miceThiago Alves da Costa, Jacob N Peterson, Julie Lang, et al.
Frontiers in Oncology|November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse modelsJulie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of the American Dental Association (1939)|January 2, 2007
Occlusal discrepanciesJeremy Shulman
Journal of the California Dental Association|January 29, 2016
TMD Controversy ContinuesJeremy Shulman
Proceedings of the National Academy of Sciences of the United States of America|April 14, 2021
Central human B cell tolerance manifests with a distinctive cell phenotype and is enforced via CXCR4 signaling in hu-miceThiago Alves da Costa, Jacob N Peterson, Julie Lang, et al.
Frontiers in Oncology|November 24, 2022
Cabozantinib sensitizes microsatellite stable colorectal cancer to immune checkpoint blockade by immune modulation in human immune system mouse modelsJulie Lang, Alexis D Leal, Juan A Marín-Jiménez, et al.
Frontiers in Immunology|April 15, 2021
Testing Cancer Immunotherapy in a Human Immune System Mouse Model: Correlating Treatment Responses to Human Chimerism, Therapeutic Variables and Immune Cell PhenotypesJuan A Marín-Jiménez, Anna Capasso, Matthew S Lewis, et al.
Pageof 1